Adam Hanina

Adam Hanina is co-founder and Board Director of AiCure, a venture and NIH-funded company that has developed an artificial intelligence platform for continuous patient monitoring of clinical trial participants and high-risk patients. Mr. Hanina has been responsible for much of the vision and strategy at AiCure and is the primary inventor of over 20 patents. Prior to AiCure, Mr. Hanina contributed to the development of Cerner Corporation's European strategy and was a Visiting Fellow of eHealth at Imperial College in London, UK. He has acted as a subject-matter expert on patient monitoring technologies for the National Institutes of Health (NIH).

Hanina previously served as the CEO of AiCure for a decade between 2010 and 2020, before continuing on to becoming the Director of the Board.

Adam Hanina received education from multiple colleges as follows:

• Brown University (BA in Physics and Economics)
• The University of Cambridge (MPHIL, Management)
• The University of Pennsylvania, The Wharton School (MBA)